Immunohistochemical analysis revealed predominantly higher expression (immunoreactivity score of 2+) of eIF5A and CD204 in tumor stromal lesions than in nontumor stromal lesions; lower expression levels of these proteins were more common in noncancer stromal lesions (all p < 0.001) (Fig. 6f). The gene discussed is EIF5A; the disease is neoplasm.